Breast Implants Linked to Cancer
April 3rd, 2017
FDA Report Links Cancer to Certain Breast Implants
According to a report released by the Federal Drug Agency (FDA), there is a rare T-cell lymphoma that can develop following breast implantation. The cancer is called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). It is considered rare, but women with breast implants involving textured implants particularly are considered to have a slightly elevated risk of developing this cancer. As of February 1st of this year, the FDA had received 359 reports of this cancer including nine deaths. Typically, it is treated by removal of the implants and then chemotherapy and/or radiation.
Information on the implants was not available on all of the cases recorded. However, there were 231 cases with information on the surface or shell of the implant and of those, 203 of those were textured implants. 312 of the reports included data regarding the solution used to fill the implants. Of those 186 were silicone and 126 were saline. This would tend to indicate that the texture of the implant is linked to the cancer, not the solution inside.